Relief Therapeutics Holding AG
RLFTD · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $34,718 | $34,409 | $32,157 | $33,227 |
| - Cash | $15,080 | $10,728 | $14,556 | $12,792 |
| + Debt | $2,143 | $2,417 | $4,311 | $4,552 |
| Enterprise Value | $21,781 | $26,098 | $21,912 | $24,987 |
| Revenue | $2,836 | $5,581 | $3,010 | $3,023 |
| % Growth | -49.2% | 85.4% | -0.4% | – |
| Gross Profit | -$1,796 | -$903 | -$5,140 | -$5,719 |
| % Margin | -63.3% | -16.2% | -170.8% | -189.2% |
| EBITDA | -$14,208 | -$2,518 | -$45,853 | -$62,349 |
| % Margin | -501% | -45.1% | -1,523.4% | -2,062.5% |
| Net Income | -$12,562 | -$4,557 | -$41,682 | -$56,499 |
| % Margin | -442.9% | -81.7% | -1,384.8% | -1,869% |
| EPS Diluted | -1 | -0.36 | -3.32 | -5.1 |
| % Growth | -177.8% | 89.2% | 34.9% | – |
| Operating Cash Flow | $359 | -$3,087 | -$7,053 | -$10,466 |
| Capital Expenditures | -$14 | -$86 | -$77 | -$369 |
| Free Cash Flow | $345 | -$3,173 | -$7,130 | -$10,835 |